insurers

Medicare patients don’t share in drug discounts given insurers and PBMs
Medicare patients don’t share in drug discounts given insurers and PBMs
Stat
Medicare
drug discounts
insurers
PBMs
Flag link:
Amgen inks first money-back guarantee for Repatha
Amgen inks first money-back guarantee for Repatha
BioPharma Dive
Amgen
Repatha
insurers
Flag link:
How Trump’s First 100 Days Affected the Healthcare Industry
How Trump’s First 100 Days Affected the Healthcare Industry
Motley Fool
Donald Trump
Express Scripts
Anthem
insurers
Akorn
Fresenius
Flag link:
Another US insurer places limits on Spinraza coverage
Another US insurer places limits on Spinraza coverage
BioPharma Dive
Biogen
Spinraza
spinal muscular atrophy
insurers
Humana
Flag link:
Harris Poll: Only Nine Percent Of U.S. Consumers Believe Pharma And Biotechnology Put Patients Over Profits
Harris Poll: Only Nine Percent Of U.S. Consumers Believe Pharma And Biotechnology Put Patients Over Profits
TheStreet.com
patients
pharma industry
insurers
Flag link:
Will Insurers Pay For Sarepta’s DMD Drug?
Will Insurers Pay For Sarepta’s DMD Drug?
Barron's
Sarepta
Duchenne Muscular Dystrophy
Exondys 51
Medicaid
payers
insurers
Flag link:
Appeals court overturns Stryker’s $9m win over insurer in Duracon Uni-Knee implants case
Appeals court overturns Stryker’s $9m win over insurer in Duracon Uni-Knee implants case
Mass Device
Stryker
Duracon Uni-Knee
insurers
devices
knee implants
Flag link:
Insurers pay more for multiple sclerosis drug because rebates don’t help, report says
Insurers pay more for multiple sclerosis drug because rebates don’t help, report says
Stat/Pharmalot
insurers
multiple sclerosis
MS
rebates
Flag link:
Another big insurer will pay for key drugs based on patient outcomes
Another big insurer will pay for key drugs based on patient outcomes
Stat
insurers
payers
patient outcomes
Flag link:
Specialty Drugs Added $87 More To Each Enrollee's Tab, Blue Cross Says
Specialty Drugs Added $87 More To Each Enrollee's Tab, Blue Cross Says
Forbes
specialty medicines
Blue Cross
insurers
drug pricing
Flag link:
Seven New York insurers end restrictions on coverage for hepatitis C drugs
Seven New York insurers end restrictions on coverage for hepatitis C drugs
BioPharma Dive
New York
insurers
hepatitis C
Merck
Zepatier
Gilead Sciences
Harvoni
Flag link:
US to pay more to insurers who provide Medicare Advantage in 2017
US to pay more to insurers who provide Medicare Advantage in 2017
Mass Device
insurers
Medicare
Medicare Advantage
Flag link:
Insurers Don't Want to Pay for Pricey Cancer Meds
Insurers Don't Want to Pay for Pricey Cancer Meds
Motley Fool
insurers
cancer
Flag link:
Sanofi's Challenge: Unrestricted Insurance Coverage For MannKind's Afrezza
Sanofi's Challenge: Unrestricted Insurance Coverage For MannKind's Afrezza
Seeking Alpha
Sanofi
MannKind
Afrezza
diabetes
insurers
Flag link:
Pfizer CEO: Drug-pricing snafu isn't pharma's fault. It's insurers and their poor coverage
Pfizer CEO: Drug-pricing snafu isn't pharma's fault. It's insurers and their poor coverage
Fierce Pharma
Ian Read
Pharma CEOs
Pfizer
drug pricing
insurers
Flag link:
2 major insurers draw lines in the sand for pricey PCSK9 coverage
2 major insurers draw lines in the sand for pricey PCSK9 coverage
BioPharma Dive
PCSK9 inhibitors
insurers
Regeneron
Sanofi
Amgen
Praluent
Repatha
Flag link:
Vantage Point - U.S. Insurer Mergers Shrink Drug Buyer Pool
Vantage Point - U.S. Insurer Mergers Shrink Drug Buyer Pool
Seeking Alpha
insurers
Aetna
Anthem
United Health
Cigna
M&A
Flag link:
Is the Cigna–Anthem Merger a Setup?
Is the Cigna–Anthem Merger a Setup?
Yahoo/Market Realist
Cigna
Anthem
M&A
insurers
Flag link:
Insurer M&A endangers pharma's pricing power, particularly in cancer: Moody's
Insurer M&A endangers pharma's pricing power, particularly in cancer: Moody's
Fierce Pharma
drug pricing
insurers
Flag link:
Aetna-Humana Deal Could Create PBM, Ending CVS Relationship
Aetna-Humana Deal Could Create PBM, Ending CVS Relationship
Forbes
Aetna
Humana
PBMs
CVS
M&A
insurers
Flag link: